• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非甾体抗炎药在老年人中的药代动力学。

The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly.

作者信息

Woodhouse K W, Wynne H

出版信息

Clin Pharmacokinet. 1987 Feb;12(2):111-22. doi: 10.2165/00003088-198712020-00002.

DOI:10.2165/00003088-198712020-00002
PMID:3549104
Abstract

The elderly often suffer from chronic musculoskeletal disease, and non-steroidal anti-inflammatory drugs (NSAIDs) are widely used to control symptoms. The aged have been shown to be particularly at risk of adverse effects from these drugs, of which gastrointestinal irritation and bleeding are both common and potentially serious. Because of this, a comparison of NSAID pharmacokinetics in young and elderly subjects is of particular importance. In general, protein binding tends to decrease with age; volumes of distribution may undergo a small increase; and clearance, especially of renally eliminated drugs, may fall. However, these changes are relatively minor, and the increased propensity of the elderly to suffer adverse reactions to NSAIDs cannot readily be explained on a pharmacokinetic basis.

摘要

老年人常患慢性肌肉骨骼疾病,非甾体抗炎药(NSAIDs)被广泛用于控制症状。已表明老年人尤其易受这些药物不良反应的影响,其中胃肠道刺激和出血既常见又可能很严重。因此,比较年轻和老年受试者中NSAIDs的药代动力学尤为重要。一般来说,蛋白质结合率往往会随着年龄增长而降低;分布容积可能会略有增加;清除率,尤其是经肾脏排泄药物的清除率,可能会下降。然而,这些变化相对较小,老年人对NSAIDs不良反应增加的倾向不能轻易从药代动力学角度来解释。

相似文献

1
The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly.非甾体抗炎药在老年人中的药代动力学。
Clin Pharmacokinet. 1987 Feb;12(2):111-22. doi: 10.2165/00003088-198712020-00002.
2
Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.非甾体抗炎药的药代动力学药物相互作用。
Clin Pharmacokinet. 1990 Jul;19(1):44-66. doi: 10.2165/00003088-199019010-00004.
3
Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.蛋白质结合作为非甾体抗炎药临床药代动力学特性的主要决定因素。
Clin Pharmacokinet. 1987 Jun;12(6):402-32. doi: 10.2165/00003088-198712060-00002.
4
Pharmacokinetics of piroxicam: new aspects.
Eur J Rheumatol Inflamm. 1987;8(1):42-8.
5
The effect of ageing with and without non-steroidal anti-inflammatory drugs on gastrointestinal microbiology and immunology.
Br J Nutr. 2008 Jul;100(1):130-7. doi: 10.1017/S000711450888871X. Epub 2008 Feb 18.
6
Is dose adjustment of non-steroidal anti-inflammatory drugs necessary in the elderly? A review of the pharmacokinetics of NSAID in the aged.
Neth J Med. 1987 Jun;30(5-6):248-58.
7
Upper gastrointestinal symptoms and therapies in elderly out-patients, users of non-selective NSAIDs or coxibs.使用非选择性非甾体抗炎药或昔布类药物的老年门诊患者的上消化道症状及治疗
Aliment Pharmacol Ther. 2005 Jul 15;22(2):147-55. doi: 10.1111/j.1365-2036.2005.02537.x.
8
Nonsteroidal anti-inflammatory drugs in the elderly.老年人使用非甾体抗炎药
Pain Manag Nurs. 2000 Jun;1(2):40-50. doi: 10.1053/jpmn.2000.7779.
9
Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest.非甾体抗炎药在兽医关注物种中的药效学和药代动力学。
J Vet Pharmacol Ther. 2004 Dec;27(6):479-90. doi: 10.1111/j.1365-2885.2004.00617.x.
10
Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.老年膝骨关节炎患者使用非选择性非甾体抗炎药和COX-2抑制剂的胃肠道及心血管风险
J Med Assoc Thai. 2009 Dec;92 Suppl 6:S19-26.

引用本文的文献

1
Nonsteroidal anti-inflammatory drugs alter vasa recta diameter via pericytes.非甾体抗炎药通过周细胞改变直小血管直径。
Am J Physiol Renal Physiol. 2015 Oct 1;309(7):F648-57. doi: 10.1152/ajprenal.00199.2015. Epub 2015 Jul 22.
2
Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics.骨关节炎老年人常用镇痛药的不良反应:聚焦于非阿片类和阿片类镇痛药。
Am J Geriatr Pharmacother. 2012 Dec;10(6):331-42. doi: 10.1016/j.amjopharm.2012.09.004. Epub 2012 Oct 2.
3
Pain management for dentists: the role of ibuprofen.

本文引用的文献

1
Age differences in the water content of the body as related to basal oxygen consumption in males.男性身体水分含量与基础氧消耗的年龄差异。
J Gerontol. 1963 Jan;18:1-8. doi: 10.1093/geronj/18.1.1.
2
The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material.保泰松(布他唑立丁)在人体中的生理处置及其在生物材料中的测定方法。
J Pharmacol Exp Ther. 1953 Nov;109(3):346-57.
3
Transsynovial distribution of ibuprofen in arthritic patients.布洛芬在关节炎患者中的滑膜分布情况。
牙医的疼痛管理:布洛芬的作用
Ann Stomatol (Roma). 2011 Jul;2(3-4 Suppl):3-24. Epub 2012 Apr 15.
4
Non-steroidal Anti-inflammatory Drugs: Monitoring to help prevent serious adverse effects.非甾体抗炎药:监测以帮助预防严重不良反应。
Can Fam Physician. 1991 Jan;37:171-80.
5
Influence of age on the enantiomeric disposition of ibuprofen in healthy volunteers.年龄对健康志愿者体内布洛芬对映体处置的影响。
Br J Clin Pharmacol. 2003 Jun;55(6):579-87. doi: 10.1046/j.1365-2125.2003.01806.x.
6
Influence of age and cytochrome P450 2C9 genotype on the steady-state disposition of diclofenac and celecoxib.年龄和细胞色素P450 2C9基因型对双氯芬酸和塞来昔布稳态处置的影响。
Clin Pharmacokinet. 2003;42(3):283-92. doi: 10.2165/00003088-200342030-00003.
7
Pain in nursing home residents: management strategies.养老院居民的疼痛:管理策略
Drugs Aging. 2001;18(1):13-29. doi: 10.2165/00002512-200118010-00002.
8
Articular diffusion of meloxicam after a single oral dose: relationship to cyclo-oxygenase inhibition in synovial cells.单次口服剂量后美洛昔康的关节扩散:与滑膜细胞中环氧化酶抑制作用的关系。
Clin Pharmacokinet. 2000 Nov;39(5):369-82. doi: 10.2165/00003088-200039050-00005.
9
Choosing the right nonsteroidal anti-inflammatory drug for the right patient: a pharmacokinetic approach.为合适的患者选择合适的非甾体抗炎药:一种药代动力学方法。
Clin Pharmacokinet. 2000 May;38(5):377-92. doi: 10.2165/00003088-200038050-00001.
10
Selective inhibitors of cyclooxygenase-2. Potential in elderly patients.环氧化酶-2选择性抑制剂。在老年患者中的潜力。
Drugs Aging. 1996 Dec;9(6):406-17. doi: 10.2165/00002512-199609060-00004.
Clin Pharmacol Ther. 1981 Apr;29(4):487-92. doi: 10.1038/clpt.1981.67.
4
The influence of food on the absorption of diclofenac as determined by the urinary excretion of the unchanged drug and its major metabolites during chronic administration.通过长期给药期间未改变药物及其主要代谢产物的尿排泄量来确定食物对双氯芬酸吸收的影响。
Eur J Clin Pharmacol. 1981 Jan;19(1):39-44. doi: 10.1007/BF00558382.
5
Pharmacokinetics of ketoprofen following single oral, intramuscular and rectal doses and after repeated oral administration.酮洛芬单次口服、肌内注射和直肠给药后以及重复口服给药后的药代动力学。
Eur J Clin Pharmacol. 1980 Nov;18(5):407-14. doi: 10.1007/BF00636794.
6
Ketoprofen pharmacokinetics and bioavailability based on an improved sensitive and specific assay.基于一种改进的灵敏且特异的检测方法的酮洛芬药代动力学和生物利用度
Eur J Clin Pharmacol. 1981;20(2):127-33. doi: 10.1007/BF00607149.
7
Clinical Pharmacokinetics of indomethacin.吲哚美辛的临床药代动力学
Clin Pharmacokinet. 1981 Jul-Aug;6(4):245-58. doi: 10.2165/00003088-198106040-00001.
8
Pharmacokinetics of azapropazone in the elderly.阿扎丙宗在老年人中的药代动力学。
Br J Clin Pharmacol. 1982 Jul;14(1):116-9. doi: 10.1111/j.1365-2125.1982.tb04947.x.
9
Pharmacokinetic studies of benoxaprofen in geriatric patients.苯恶洛芬在老年患者中的药代动力学研究。
Eur J Rheumatol Inflamm. 1982;5(2):76-81.
10
The pharmacokinetics of benoxaprofen in elderly subjects.老年人中苯恶洛芬的药代动力学。
Eur J Rheumatol Inflamm. 1982;5(2):69-75.